tirzepatide cardiovascular outcome outcomes An Observational Study of of vs Glucagon-Like Peptide-1 Receptor Agonists In patients with type 2 tirzepatide cardiovascular outcomes trial 2024

Often hyperinsulinemia, which is exaggerated by high levels of androgens, is considered a main characteristic of PCOS

GLP-1 medications can compound this through smaller portion sizes and reduced dietary diversity

doi: 10.1016/S0002-9343(98)00168-5 340 RimesKALievesleyKChalderT

Peptides don't tolerate improvisation, and the protocols that feel most rigid are usually the ones that produce the most reliable results

While weight management isnt a universal struggle for people with this condition, many people with PCOS express frustration when trying to lose weight

Most side effects of sermorelin are mild, but ongoing monitoring (including periodic blood tests for IGF-1 and other parameters) is part of therapy to ensure safety